Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

Pan L, Woodard JL, Lucas DM, Fuchs JR, Kinghorn AD.

Nat Prod Rep. 2014 Jul;31(7):924-39. doi: 10.1039/c4np00006d. Epub 2014 May 2. Review.

2.

New rocaglamide derivatives from Vietnamese Aglaia species.

Duong NT, Edrada-Ebel R, Ebel R, Lin W, Duong AT, Dang XQ, Nguyen NH, Proksch P.

Nat Prod Commun. 2014 Jun;9(6):833-4.

PMID:
25115092
3.

Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.

Othman N, Pan L, Mejin M, Voong JC, Chai HB, Pannell CM, Kinghorn AD, Yeo TC.

J Nat Prod. 2016 Apr 22;79(4):784-91. doi: 10.1021/acs.jnatprod.5b00810. Epub 2016 Mar 14.

4.

Cytotoxic rocaglamide derivatives from Aglaia duppereana.

El-Neketi M, Ebrahim W, Duong NT, Gedara S, Badria F, Saad HE, Müller WE, Proksch P.

Z Naturforsch C. 2013 Jul-Aug;68(7-8):269-74.

PMID:
24066511
5.

Bioactive flavaglines and other constituents isolated from Aglaia perviridis.

Pan L, Acuña UM, Li J, Jena N, Ninh TN, Pannell CM, Chai H, Fuchs JR, Carcache de Blanco EJ, Soejarto DD, Kinghorn AD.

J Nat Prod. 2013 Mar 22;76(3):394-404. doi: 10.1021/np3007588. Epub 2013 Jan 9.

6.

Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

Kim S, Salim AA, Swanson SM, Kinghorn AD.

Anticancer Agents Med Chem. 2006 Jul;6(4):319-45. Review.

PMID:
16842234
7.

Ponapensin, a cyclopenta[bc]benzopyran with potent NF-kappaB inhibitory activity from Aglaia ponapensis.

Salim AA, Pawlus AD, Chai HB, Farnsworth NR, Douglas Kinghorn A, Carcache-Blanco EJ.

Bioorg Med Chem Lett. 2007 Jan 1;17(1):109-12. Epub 2006 Sep 30.

8.

Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

Hwang BY, Su BN, Chai H, Mi Q, Kardono LB, Afriastini JJ, Riswan S, Santarsiero BD, Mesecar AD, Wild R, Fairchild CR, Vite GD, Rose WC, Farnsworth NR, Cordell GA, Pezzuto JM, Swanson SM, Kinghorn AD.

J Org Chem. 2004 May 14;69(10):3350-8. Erratum in: J Org Chem. 2004 Sep 3;69(18):6156.

PMID:
15132542
9.

Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.

Pan L, Kardono LB, Riswan S, Chai H, Carcache de Blanco EJ, Pannell CM, Soejarto DD, McCloud TG, Newman DJ, Kinghorn AD.

J Nat Prod. 2010 Nov 29;73(11):1873-8. doi: 10.1021/np100503q. Epub 2010 Oct 12.

10.

Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4'-desmethoxyepisilvestrol.

Adams TE, El Sous M, Hawkins BC, Hirner S, Holloway G, Khoo ML, Owen DJ, Savage GP, Scammells PJ, Rizzacasa MA.

J Am Chem Soc. 2009 Feb 4;131(4):1607-16. doi: 10.1021/ja808402e.

PMID:
19140688
11.

Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae).

Bohnenstengel FI, Steube KG, Meyer C, Nugroho BW, Hung PD, Kiet LC, Proksch P.

Z Naturforsch C. 1999 Jan-Feb;54(1-2):55-60.

PMID:
10223787
12.

1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines.

Bohnenstengel FI, Steube KG, Meyer C, Quentmeier H, Nugroho BW, Proksch P.

Z Naturforsch C. 1999 Dec;54(12):1075-83.

PMID:
10685499
13.

Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).

Ebada SS, Lajkiewicz N, Porco JA Jr, Li-Weber M, Proksch P.

Prog Chem Org Nat Prod. 2011;94:1-58. doi: 10.1007/978-3-7091-0748-5_1. Review. No abstract available.

14.

Insecticidal rocaglamide derivatives from Aglaia spectabilis (Meliaceae).

Schneider C, Bohnenstengel FI, Nugroho BW, Wray V, Witte L, Hung PD, Kiet LC, Proksch P.

Phytochemistry. 2000 Aug;54(8):731-6.

PMID:
11014256
15.

Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells.

Proksch P, Giaisi M, Treiber MK, Palfi K, Merling A, Spring H, Krammer PH, Li-Weber M.

J Immunol. 2005 Jun 1;174(11):7075-84.

16.

Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.

Rivero-Cruz JF, Chai HB, Kardono LB, Setyowati FM, Afriatini JJ, Riswan S, Farnsworth NR, Cordell GA, Pezzuto JM, Swanson SM, Kinghorn AD.

J Nat Prod. 2004 Mar;67(3):343-7.

PMID:
15043407
17.

Triterpenoids from Aglaia abbreviata and their cytotoxic activities.

Zhang F, Wang JS, Gu YC, Kong LY.

J Nat Prod. 2010 Dec 27;73(12):2042-6. doi: 10.1021/np100599g. Epub 2010 Nov 18.

PMID:
21087017
18.

New insecticidal rocaglamide derivatives and related compounds from Aglaia oligophylla.

Dreyer M, Nugroho BW, Bohnenstengel FI, Ebel R, Wray V, Witte L, Bringmann G, Mühlbacher J, Herold M, Hung PD, Kiet LC, Proksch P.

J Nat Prod. 2001 Apr;64(4):415-20.

PMID:
11325219
19.

Amide-esters from Aglaia tenuicaulis--first representatives of a class of compounds structurally related to bisamides and flavaglines.

Greger H, Hofer M, Teichmann K, Schinnerl J, Pannell CM, Vajrodaya S, Hofer O.

Phytochemistry. 2008 Feb;69(4):928-38. Epub 2007 Dec 21.

PMID:
18155259
20.

Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.

Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, Debatin KM, Proksch P, Wirth T.

J Biol Chem. 2002 Nov 22;277(47):44791-800. Epub 2002 Sep 16.

Supplemental Content

Support Center